Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anastomotic Leak × Neomycin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Surgical Wound Infection 2 Rectal Neoplasms 1 Postoperative Complications 1 Inflammatory Bowel Diseases 1 Diverticulitis 1 Anastomotic Leak 1

Interventions

Stents 2 Serum Albumin, Human 2 Ileostomy 2 obsidian 1 Water 1 Tomography, X-Ray Computed 1 Tobramycin 1 Tissue Adhesives 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Robotic Surgical Procedures 1 Proctectomy 1 Neomycin 1 Neoadjuvant Therapy 1 Negative-Pressure Wound Therapy 1 Mortality 1 Metronidazole 1 Laparotomy 1 Inulin 1 Indocyanine Green 1 Fibrin Tissue Adhesive 1 Esophagectomy 1 Endoscopy 1 Enbucrilate 1 Diathermy 1 Colistin 1 Colectomy 1 Ciprofloxacin 1 Cathartics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡